These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25824664)

  • 41. Microbial Oxidation of the Fusidic Acid Side Chain by
    Ibrahim AS; Elokely KM; Ferreira D; Ragab AE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29690500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The postantibiotic effect of fusidic acid against gram-positive bacteria.
    Munckhof WJ; Turnidge JD
    J Antimicrob Chemother; 1997 Sep; 40(3):433-6. PubMed ID: 9338499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fusidic acid resistance in Staphylococcus aureus isolates.
    Brown EM; Thomas P
    Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
    [No Abstract]   [Full Text] [Related]  

  • 44. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus.
    Erdenizmenli M; Yapar N; Sengönül A; Yüce A; Cakir N; Yulug N
    J Chemother; 2004 Jun; 16(3):310-1. PubMed ID: 15330332
    [No Abstract]   [Full Text] [Related]  

  • 45. New Helvolic Acid Derivatives with Antibacterial Activities from
    Zhang ZB; Du SY; Ji B; Ji CJ; Xiao YW; Yan RM; Zhu D
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
    Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
    J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antibacterial activity of 4″-O-(trans-β-arylacrylamido)carbamoyl azithromycin analogs.
    Yan M; Ma X; Dong R; Li X; Zhao C; Guo Z; Shen Y; Liu F; Ma R; Ma S
    Eur J Med Chem; 2015 Oct; 103():506-15. PubMed ID: 26402728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
    Sader HS; Flamm RK; Farrell DJ; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone.
    Jin X; Zheng CJ; Song MX; Wu Y; Sun LP; Li YJ; Yu LJ; Piao HR
    Eur J Med Chem; 2012 Oct; 56():203-9. PubMed ID: 22982124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents.
    Al-Trawneh SA; El-Abadelah MM; Al-Abadleh MM; Zani F; Incerti M; Vicini P
    Eur J Med Chem; 2014 Oct; 86():364-7. PubMed ID: 25180924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
    Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
    J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fusidic acid derivatives from the endophytic fungus
    Tian C; Gao H; Peng XP; Li G; Lou HX
    J Asian Nat Prod Res; 2021 Dec; 23(12):1148-1155. PubMed ID: 33455458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and structure-activity relationship studies of conformationally restricted mutilin 14-carbamates.
    Fu L; Liu X; Ling C; Cheng J; Guo X; He H; Ding S; Yang Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):814-9. PubMed ID: 22209487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives.
    Cabral V; Luo X; Junqueira E; Costa SS; Mulhovo S; Duarte A; Couto I; Viveiros M; Ferreira MJ
    Phytomedicine; 2015 Apr; 22(4):469-76. PubMed ID: 25925969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 17S,20S-Methanofusidic acid, a new potent semi-synthetic fusidane antibiotic.
    Duvold T; Jørgensen A; Andersen NR; Henriksen AS; Dahl Sørensen M; Björkling F
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3569-72. PubMed ID: 12443778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.
    Xiao T; Liu K; Huigens RW
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127515. PubMed ID: 32860978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NF-κB Inhibitory and Antibacterial Helvolic and Fumagillin Derivatives from
    Zaman KAU; Hu Z; Wu X; Hou S; Saito J; Kondratyuk TP; Pezzuto JM; Cao S
    J Nat Prod; 2020 Mar; 83(3):730-737. PubMed ID: 32163285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity.
    Singh K; Kaur G; Shanika PS; Dziwornu GA; Okombo J; Chibale K
    Bioorg Med Chem; 2020 Jul; 28(13):115530. PubMed ID: 32362386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.